secwatch.observer — SEC 8-K summary
======================================

Issuer:     GeoVax Labs, Inc. (GOVX)
CIK:        0000832489
Form:       8-K
Filed at:   2022-12-08T23:59:59+00:00
Accession:  0001437749-22-028740
Event type: leadership
Sentiment:  positive
Materiality: 0.45
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

GeoVax appoints Dr. Jayne Morgan to Board; adopts 2023 Stock Incentive Plan
---------------------------------------------------------------------------

- Appointed Jayne Morgan, M.D. to Board effective Dec 7, 2022; brings expertise in COVID-19 management and health equity.
- Morgan will serve on Nominating & Governance Committee and receive pro-rata director compensation.
- Board approved 2023 Stock Incentive Plan, subject to shareholder approval, authorizing up to 3M shares of common stock.
- 2023 Plan replaces 2020 Stock Incentive Plan; no further grants under Prior Plan after effective date.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/832489/000143774922028740/0001437749-22-028740-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/832489/000143774922028740/govx20221207_8k.htm
  HTML page:      https://secwatch.observer/filing/0001437749-22-028740

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer